News
Barrington Research raised DENTSPLY SIRONA Inc. XRAY price target from $20 to $21. Barrington Research analyst Michael ...
Intellia Therapeutics reported further progress with two treatments that are now ensconced in Phase III of testing. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback